Shoucheng (00697) spent 19.9915 million Hong Kong dollars on January 2nd to repurchase 9.182 million shares.
First Journey Holdings (00697) announced that on January 2, 2026, the company spent 1999.15 million Hong Kong dollars to repurchase 9.182 million shares, with a repurchase price of 2.13-2.19 Hong Kong dollars per share.
SHOUCHENG (00697) announces that on January 2, 2026, the company will spend 1999.15 million Hong Kong dollars to repurchase 9.182 million shares, with a repurchase price of 2.13-2.19 Hong Kong dollars per share.
Related Articles
CSPC PHARMA (01093): Nintedanib Ethanesulfonate Inhalation Powder Aerosol Approved for Clinical Trials in China.
"A+H" stock craze continues! In December, a total of 27 A-share listed companies are planning to go public in Hong Kong, with CPO leader Suzhou TFC Optical Communication among them.
REDCO HEALTHY (02370): There is currently no information available on how the pledged shares will be handled in the event of the forced execution by the administrator.
CSPC PHARMA (01093): Nintedanib Ethanesulfonate Inhalation Powder Aerosol Approved for Clinical Trials in China.
"A+H" stock craze continues! In December, a total of 27 A-share listed companies are planning to go public in Hong Kong, with CPO leader Suzhou TFC Optical Communication among them.
REDCO HEALTHY (02370): There is currently no information available on how the pledged shares will be handled in the event of the forced execution by the administrator.
